Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) ...

In today’s fast-moving world of applied biotechnology, Ravi Narayan Venkatachalam is shaping the systems behind the solutions ...

Genentech announced a third round of layoffs, affecting 143 jobs, as part of its strategic workforce adjustments, amid broader job cuts across various sectors in Northern California.

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation in the graft versus host ...

Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...

The study, led from the University of Utah, analyzed 3,286 hospitals across the country, using data from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, which ran ...

Genentech is letting go of 143 employees who are based out of the company's headquarters in South San Francisco. | Genentech ...

After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

A fresh wave of layoffs is sweeping across Northern California, with job cuts spanning the biotech, retail, agriculture and health care sectors — signaling mounting economic pressures in the region.